Ami Organics Limited (AMIORG) - Net Assets

Latest as of March 2025: Rs13.20 Billion INR ≈ $142.76 Million USD

Based on the latest financial reports, Ami Organics Limited (AMIORG) has net assets worth Rs13.20 Billion INR (≈ $142.76 Million USD) as of March 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs15.49 Billion ≈ $167.55 Million USD) and total liabilities (Rs2.29 Billion ≈ $24.79 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Ami Organics Limited liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets Rs13.20 Billion
% of Total Assets 85.21%
Annual Growth Rate 54.82%
5-Year Change 690.78%
10-Year Change 4713.6%
Growth Volatility 53.26

Ami Organics Limited - Net Assets Trend (2014–2025)

This chart illustrates how Ami Organics Limited's net assets have evolved over time, based on quarterly financial data. Also explore Ami Organics Limited asset portfolio for the complete picture of this company's asset base.

Annual Net Assets for Ami Organics Limited (2014–2025)

The table below shows the annual net assets of Ami Organics Limited from 2014 to 2025. For live valuation and market cap data, see market value of Ami Organics Limited.

Year Net Assets Change
2025-03-31 Rs13.20 Billion
≈ $142.76 Million
+93.35%
2024-03-31 Rs6.83 Billion
≈ $73.84 Million
+14.95%
2023-03-31 Rs5.94 Billion
≈ $64.23 Million
+13.73%
2022-03-31 Rs5.22 Billion
≈ $56.48 Million
+212.86%
2021-03-31 Rs1.67 Billion
≈ $18.05 Million
+49.30%
2020-03-31 Rs1.12 Billion
≈ $12.09 Million
+36.00%
2019-03-31 Rs822.19 Million
≈ $8.89 Million
+42.54%
2018-03-31 Rs576.82 Million
≈ $6.24 Million
+47.93%
2017-03-31 Rs389.92 Million
≈ $4.22 Million
+42.18%
2016-03-31 Rs274.24 Million
≈ $2.97 Million
+84.91%
2015-03-31 Rs148.31 Million
≈ $1.60 Million
+37.67%
2014-03-31 Rs107.73 Million
≈ $1.17 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Ami Organics Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (March 2025)

Component Amount Percentage
Common Stock Rs409.35 Million 3.13%
Other Comprehensive Income Rs12.69 Billion 96.87%
Total Equity Rs13.10 Billion 100.00%

Ami Organics Limited Competitors by Market Cap

The table below lists competitors of Ami Organics Limited ranked by their market capitalization.

Company Market Cap
Ramsay Generale De Sante
PA:GDS
$1.18 Billion
Rio Tinto PLC
LSE:RIO
$1.18 Billion
Luye Pharma Group Ltd
F:LUP
$1.18 Billion
United Corporations Limited
TO:UNC
$1.18 Billion
Medartis Holding AG
SW:MED
$1.17 Billion
Changzhou Tronly New Electronic Materials Co Ltd
SHE:300429
$1.17 Billion
Shanghai Zhongzhou Special Alloy Materials Co. Ltd.
SHE:300963
$1.17 Billion
Henan Hengxing Science & Technology Co Ltd
SHE:002132
$1.17 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Ami Organics Limited's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 6,739,974,000 to 13,096,287,000, a change of 6,356,313,000 (94.3%).
  • Net income of 1,587,136,000 contributed positively to equity growth.
  • Dividend payments of 122,783,000 reduced retained earnings.
  • New share issuances of 4,993,889,000 increased equity.
  • Other comprehensive income increased equity by 12,643,878,000.
  • Other factors decreased equity by 12,745,807,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income Rs1.59 Billion +12.12%
Dividends Paid Rs122.78 Million -0.94%
Share Issuances Rs4.99 Billion +38.13%
Other Comprehensive Income Rs12.64 Billion +96.55%
Other Changes Rs-12.75 Billion -97.32%
Total Change Rs- 94.31%

Book Value vs Market Value Analysis

This analysis compares Ami Organics Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 8.12x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 345.00x to 8.12x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2014-03-31 Rs3.85 Rs1327.40 x
2015-03-31 Rs5.30 Rs1327.40 x
2016-03-31 Rs8.51 Rs1327.40 x
2017-03-31 Rs12.10 Rs1327.40 x
2018-03-31 Rs17.90 Rs1327.40 x
2019-03-31 Rs22.56 Rs1327.40 x
2020-03-31 Rs35.50 Rs1327.40 x
2021-03-31 Rs52.99 Rs1327.40 x
2022-03-31 Rs152.69 Rs1327.40 x
2023-03-31 Rs163.01 Rs1327.40 x
2024-03-31 Rs183.73 Rs1327.40 x
2025-03-31 Rs163.46 Rs1327.40 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Ami Organics Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 12.12%
  • The company shows good efficiency in utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 15.76%
  • • Asset Turnover: 0.65x
  • • Equity Multiplier: 1.18x
  • Recent ROE (12.12%) is below the historical average (24.57%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2014 26.58% 3.77% 1.96x 3.59x Rs17.87 Million
2015 27.61% 3.68% 1.88x 3.99x Rs26.12 Million
2016 46.15% 8.28% 1.65x 3.37x Rs99.14 Million
2017 30.90% 7.74% 1.43x 2.80x Rs81.49 Million
2018 32.06% 10.08% 1.18x 2.70x Rs127.27 Million
2019 28.33% 9.77% 1.12x 2.59x Rs150.73 Million
2020 24.57% 11.46% 1.03x 2.07x Rs162.89 Million
2021 32.35% 15.85% 0.82x 2.48x Rs373.06 Million
2022 13.78% 13.88% 0.79x 1.26x Rs197.19 Million
2023 14.02% 13.50% 0.80x 1.29x Rs238.94 Million
2024 6.35% 5.96% 0.65x 1.63x Rs-246.27 Million
2025 12.12% 15.76% 0.65x 1.18x Rs277.51 Million

Industry Comparison

This section compares Ami Organics Limited's net assets metrics with peer companies in the Specialty Chemicals industry.

Industry Context

  • Industry: Specialty Chemicals
  • Average net assets among peers: $6,738,777,756
  • Average return on equity (ROE) among peers: 20.29%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Ami Organics Limited (AMIORG) Rs13.20 Billion 26.58% 0.17x $1.18 Billion
Aarti Industries Limited (AARTIIND) $5.93 Billion 17.40% 1.80x $1.90 Billion
Aarti Surfactants Limited (AARTISURF) $1.33 Billion 16.31% 1.89x $42.26 Million
ABM International Limited (ABMINTLLTD) $15.38 Million 31.24% 33.21x $4.46 Million
Advanced Enzyme Technologies Limited (ADVENZYMES) $12.84 Billion 8.23% 0.11x $432.43 Million
Aether Industries Limited (AETHER) $782.77 Million 51.04% 2.84x $1.74 Billion
Akzo Nobel India Limited (AKZOINDIA) $13.30 Billion 32.29% 1.18x $1.46 Billion
Alkali Metals Limited (ALKALI) $513.80 Million 2.54% 0.73x $7.43 Million
Alkyl Amines Chemicals Limited (ALKYLAMINE) $852.48 Million 16.37% 2.01x $959.63 Million
Anupam Rasayan India Limited (ANURAS) $25.08 Billion 7.21% 0.51x $1.69 Billion

About Ami Organics Limited

NSE:AMIORG India Specialty Chemicals
Market Cap
$1.18 Billion
Rs108.67 Billion INR
Market Cap Rank
#8531 Global
#412 in India
Share Price
Rs1327.40
Change (1 day)
+8.78%
52-Week Range
Rs1091.40 - Rs1327.40
All Time High
Rs2626.70
About

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications, as wel… Read more